Actively Recruiting

Phase Not Applicable
Age: 3Years - 6Years
All Genders
Healthy Volunteers
NCT07244120

Embodied Writing Versus Conventional Writing Practice for Handwriting

Led by Riphah International University · Updated on 2025-11-24

148

Participants Needed

1

Research Sites

15 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This randomized clinical trial will involve 148 preschooler children of age group 3 to 6 years old with handwriting difficulties from Cambridge Foundation School FSD and Behan Je Memorial school FSD, Pakistan. The participants will be divided into two groups: Group A will follow conventional writing practices with parental ergonomics guidance, while Group B will engage in embodied writing practices combined with ergonomic education for parents. Over 8 weeks, handwriting legibility, speed, and motor coordination will be assessed pre- and post-intervention using the Handwriting Proficiency Screening Questionnaire and the Minnesota Handwriting Assessment Scale. The study aims to evaluate each approach's effectiveness in addressing handwriting challenges, providing insights into embodied learning's potential impact on early childhood education. Data analysis will be conducted using SPSS version 23.

CONDITIONS

Official Title

Embodied Writing Versus Conventional Writing Practice for Handwriting

Who Can Participate

Age: 3Years - 6Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Child has poor handwriting as assessed by the HPSQ (20)
  • Child is of age between 3-6 years.
  • The child attends a regular primary school.
  • Both boys and girls will be included in the study.
Not Eligible

You will not qualify if you...

  • Developmental delay
  • Physical impairment of upper extremity
  • Hearing deficit (21)
  • Visual problem
  • Any recent trauma to upper limb
  • Gross motor impairment
  • Neurological deficit
  • Receiving any Physiotherapy before

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Imran Amjad

Lahore, Punjab Province, Pakistan, 5400

Actively Recruiting

Loading map...

Research Team

I

IMRAN AMJAD, PhD

CONTACT

M

Muhammad Asif Javed, MS-PT

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

OTHER

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here